Headquartered in Lisbon, Portugal and with presence in Spain, Mercurius focuses on the provision of radiotherapy related services such as equipment operations, procurement, installation, commissioning and training to private and public hospitals and cancer centres.
iCON acquired an 82.7% interest in Mercurius in January 2023.